Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
Nasrin Samadi, Laboratory Founder and Owner at Mehr laboratory, shared a post on LinkedIn:
“Can a Normal Clotting Test Be Misleading?
A normal PT or aPTT result does not always mean that anticoagulant activity is absent. Similarly, a prolonged aPTT does not necessarily indicate an increased risk of bleeding.
In Episode 3 of Medical Insights with Dr. Nasrin Samadi, we explore some important challenges in interpreting coagulation tests:
- Preanalytical errors: How underfilled citrate tubes or heparin contamination can affect coagulation test results.
- Lupus anticoagulant: Why a prolonged aPTT may be associated with an increased risk of thrombosis rather than bleeding.
- DOACs: Why normal PT and aPTT results cannot reliably exclude clinically significant anticoagulant effects.
- Specialized testing: When drug-specific anti-Xa assays or other specialized coagulation tests may be helpful.
The key message:
Laboratory results should never be interpreted in isolation. Understanding the patient’s clinical context is just as important as understanding the numbers.
Watch the full episode on YouTube:
A special thank you to Jeremy Bellaiche for producing this educational podcast and for his continued collaboration and support.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes